Menzies Dick, Lewis Megan, Oxlade Olivia
Montreal Chest Institute, 3650 St-Urbain, Rm K1.24, Montreal, QC.
Can J Public Health. 2008 Sep-Oct;99(5):391-6. doi: 10.1007/BF03405248.
We have estimated tuberculosis (TB)-related expenditures by governments and other third parties in Canada in 2004, in order to compare spending on different activities, by various jurisdictions, and in different regions.
To ascertain health system costs (including public health costs), a self-administered questionnaire was completed by all federal, provincial, and territorial health departments and laboratories involved in TB activities and a sample of local health departments. Hospitalization information was obtained from the Canadian Institute for Health Information, while costs for care were derived from published literature. Costs borne by patients and families were not included. All costs were ascertained for 2004 and expressed in Canadian dollars.
In 2004, total TB-related expenditures in Canada were $74 million, equivalent to $47,290 for every active TB case diagnosed in that year. Research accounted for $4.5 million (or 6% of the total). Non-research-related federal spending accounted for $16.3 million (22%) and provincial/territorial expenditures accounted for $53.1 million (72%). Active tuberculosis accounted for $31 million or 59% of provincial/territorial expenditures. There were substantial regional differences in TB-related expenditures; the highest expenditures were in the Northern Territories ($72,441 per active TB case), followed by the four Western provinces ($35,914), and lowest in the Atlantic provinces ($28,259).
Total TB-related expenditures in Canada in 2004 were considerable, of which almost 60% were for curative services and only 40% for prevention and control activities. Regional differences likely reflect differences in accessibility of the populations to health care services, and greater interventions in communities with ongoing TB transmission.
我们估算了2004年加拿大政府及其他第三方与结核病(TB)相关的支出,以便比较不同司法管辖区、不同地区在不同活动上的支出情况。
为确定卫生系统成本(包括公共卫生成本),参与结核病防治活动的所有联邦、省和地区卫生部门及实验室以及部分地方卫生部门填写了一份自填式问卷。住院信息来自加拿大卫生信息研究所,护理成本则来自已发表的文献。患者及其家庭承担的费用未包括在内。所有成本均确定为2004年的情况,并以加元表示。
2004年,加拿大与结核病相关的总支出为7400万美元,相当于当年每例确诊活动性结核病病例支出47290加元。研究支出为450万美元(占总支出的6%)。与研究无关的联邦支出为1630万美元(22%),省/地区支出为5310万美元(72%)。活动性结核病占省/地区支出的3100万美元,即59%。与结核病相关的支出存在显著的地区差异;支出最高的是西北地区(每例活动性结核病病例72441加元),其次是西部四个省份(35914加元),大西洋省份最低(28259加元)。
2004年加拿大与结核病相关的总支出相当可观,其中近60%用于治疗服务,仅40%用于预防和控制活动。地区差异可能反映了不同人群获得医疗服务的难易程度不同以及对结核病持续传播地区社区的干预力度更大。